Dow Down1.29% Nasdaq Down3.25%

ProFunds Biotechnology UltraSector Inv (BIPIX)

46.93 Down 2.62(5.29%) Feb 5

Profile as of Jan 30, 2016Get Profile for:
ProFunds Biotechnology UltraSector Inv
Profunds3435 Stelzler RdColumbus, OH 43219
Phone: 888-776-3637
Fund Overview 
Category:Trading-Leveraged Equity
Fund Family:ProFunds
Net Assets:634.15M
Year-to-Date Return:-24.37%
Morningstar Rating:4 stars
Fund Inception Date:Jun 19, 2000
Morningstar Style Box 
Trading-Leveraged Equity
[View Category Definition]
View Top Trading-Leveraged Equity Funds
About the Morningstar Style Box
Management Information 
Michael Neches
Lead Manager since Oct 1, 2013
Michael Neches: ProShare Advisors: Senior Portfolio Manager since November 2010 and Portfolio Manager from January 2010 through October 2010. ProShares Capital Management LLC: Senior Portfolio Manager from June 2012 through September 2013.
Investment Information 
Min Initial Investment:15,000
Min Initial Investment, IRA:15,000
Min Initial Investment, AIP:15,000
Min Subsequent Investment:N/A
Min Subsequent Investment, IRA:N/A
Min Subsequent Investment, AIP:N/A
BIPIX can be purchased from 85 brokerages.

Fund Summary 
The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the Dow Jones U.S. BiotechnologySM Index. The fund invests in securities and derivatives that the adviser believes, in combination, should have similar daily return characteristics as one and one-half times (1.5x) the daily return of the index. The index measures the performance of the biotechnology sector of the U.S. equity market. It is non-diversified.

Fund Operations 
Last Dividend : 0.00
Last Cap Gain (Dec 14, 2014) : 0.00
Annual Holdings Turnover (Dec 29, 2015) : 11.00%
Average for Category:270.91%
Fees & Expenses 
ExpenseBIPIXCategory Avg
Annual Report Expense Ratio (net):1.52%1.99%
Prospectus Net Expense Ratio:1.49%N/A
Prospectus Gross Expense Ratio:1.49%N/A
Max 12b1 Fee:0.00%N/A
Max Front End Sales Load:N/A4.75%
Max Deferred Sales Load: N/A1.00%
3 Yr Expense Projection*:471685
5 Yr Expense Projection*:8131,138
10 Yr Expense Projection*:1,7792,387
* Per $10,000 invested